Managing type 1 diabetes during pregnancy is one of the most demanding challenges a person with T1D can face. Blood sugar targets become tighter, insulin sensitivity shifts constantly, and the stakes feel impossibly high. For years, automated insulin delivery (AID) systems — which offer so much relief in everyday T1D management — were not approved for use during pregnancy.

That changed this spring.

A First-of-Its-Kind Approval

Breakthrough T1D announced that the first automated insulin delivery technology has been cleared in the United States for use during pregnancy with type 1 diabetes. This is a significant regulatory milestone: until now, pregnant people with T1D had to manage blood sugar without the automated support available to others.

Why This Took So Long

Clinical trials in pregnancy are ethically complex. Recruiting pregnant participants, ensuring safety for both mother and baby, and designing studies that account for the rapidly changing physiology of pregnancy all add layers of difficulty. But researchers persisted, and the data — including from the AiDAPT randomized controlled trial — eventually made the case.

The evidence showed that closed-loop systems could improve time-in-range during pregnancy without increasing adverse outcomes. For a population where tight glycemic control is critical but incredibly difficult to maintain manually, this is genuinely meaningful.

What This Means for T1D Families

For parents of children currently diagnosed with T1D, this may feel distant. But those children will grow up, and many of the girls will one day consider pregnancy. The landscape of T1D care they inherit is being shaped right now.

More immediately: if you or someone you know has T1D and is pregnant or planning a pregnancy, this is news worth bringing to an endocrinologist. Ask specifically about closed-loop systems approved for pregnancy.

The disease is being managed better with every year. That's not a cliché — it's the steady work of researchers, clinicians, and advocates who refuse to stop pushing.

Keywords: automated insulin delivery pregnancy type 1 diabetes, closed loop system pregnant T1D, AID system pregnancy approval, type 1 diabetes women pregnancy management, T1D pregnancy 2026